Clinical Trial Update: The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older [Phase 2]

View source ↗

Summary

Phase 2 trial update for Gam-COVID-Vac (Sputnik V) vaccine in volunteers aged 60 and older for coronavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Gam-COVID-Vac (unspecified)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Coronavirus Infection | Phase 2 | Status: UNKNOWN